Purchase Order 75N93020P00990

Laboratories Nexelis Canada Inc., doing business as Pairimmune, has been awarded a firm fixed-price purchase order valued at $14.56 million by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. Under this contract, Pairimmune will establish high throughput SARS-CoV-2 binding antibody immunoassay capability and test human serum samples to support the federal government's response to the COVID-19 pandemic. As the prime contractor,...

<p>The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $308,400 firm fixed price purchase order to Adaptive Biotechnologies Corporation, doing business as Adaptive, to provide COVID-19 funded immunoseq sequencing services for a COVID-19 research project. The contract will be performed in Seattle, Washington and has a period of performance from November 10, 2022 through May 10, 2023.</p>

This $19,835 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Adaptive Biotechnologies Corporation (Adaptive) for COVID-19 research and B-cell sequencing services. The contract has a period of performance through March 24, 2021. Adaptive is a commercial provider of immune-driven medicine services and products, and has previously received federal contracts and...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Adaptive Biotechnologies Corporation (&quot;Adaptive&quot;) for immunosequencing extraction services. The $12,750 contract was awarded on December 10, 2019 with a completion date of December 10, 2020. Adaptive is a commercial provider of immune-driven medicine services and products. The company has...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $14.7 million firm fixed price definitive contract to Laboratories Nexelis Canada Inc., doing business as Pairimmune, to provide high throughput SARS-CoV-2 binding antibody immunoassay testing of clinical samples from COVID-19 vaccine trials. The contract supports assay development and validation for emerging SARS-CoV-2 variants. Per the solicitation, the one-year base period...

This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Adaptive Biotechnologies Corporation (also doing business as Adaptive) for IMMUNOSEQ MMTCRB SERVICE. The contract, valued at $12,200.00, does not have a set-aside designation. Through this award, Adaptive Biotechnologies will provide specialized sequencing and testing services to support HHS research programs. Adaptive...

Pacific Immunology has been awarded a $19,813 purchase order contract by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide antibody production testing services in support of the agency's biomedical research efforts. The firm fixed price contract runs from September 2023 through September 2024 and will be performed in Ramona, California. No subcontractors or set aside designations were identified. This award...

Adaptive Biotechnologies Corporation has been awarded a firm fixed price purchase order valued at thirteen thousand two hundred dollars from the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. Under this contract, Adaptive will provide laboratory testing, adaptive immunosequencing, and DNA extraction services in support of unspecified NIH research programs. Performance will take place in Seattle, Washington through...

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,690 firm fixed-price purchase order to Adaptive Biotechnologies Corporation (doing business as Adaptive) for ImmunoSEQ sequencing services. The contract has an ultimate completion date of December 20, 2024. Adaptive is a commercial provider of immune-driven medicine services and products, and has previously received federal contracts and grants from the Department of Health and Human Services (HHS), Department...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $14,225.00 firm fixed price purchase order to Adaptive Biotechnologies Corporation, doing business as Adaptive, for immunosequencing extraction services. The contract supports NIH research programs and does not have a set-aside designation. Adaptive has previously provided specialized testing and genomic sequencing services to HHS, the Department...